Biodesix's market cap is currently $53.84M. The company's EPS TTM is $-1.6; its P/E ratio is -1.20; Biodesix is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.49. See an overview of income statement, balance sheet, and cash flow financials.
